Evidence map›Paper›PMID 40144738›Full record

ArticleGHM open2024

Prevalence of hepatitis B and C, and their linkage to care among drug abusers attending psychiatric hospital in Hiroshima, Japan.

Aya Sugiyama, Ariyuki Kagaya, Ko Ko, Zayar Phyo, Golda Ataa Akuffo, Tomoyuki Akita, Kazuaki Takahashi, Ryotaro Tsukue, Chika Shimohara, Junko Tanaka

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in GHM open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Aya SugiyamaDepartment of Epidemiology, Infectious Disease Control and Prevention Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ariyuki KagayaSenogawa Hospital, Hiroshima, Japan.
Ko KoDepartment of Epidemiology, Infectious Disease Control and Prevention Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Zayar PhyoDepartment of Epidemiology, Infectious Disease Control and Prevention Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Golda Ataa AkuffoDepartment of Epidemiology, Infectious Disease Control and Prevention Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Tomoyuki AkitaDepartment of Epidemiology, Infectious Disease Control and Prevention Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Kazuaki TakahashiDepartment of Epidemiology, Infectious Disease Control and Prevention Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
Ryotaro TsukueSenogawa Hospital, Hiroshima, Japan.
Chika ShimoharaSenogawa Hospital, Hiroshima, Japan.
Junko TanakaDepartment of Epidemiology, Infectious Disease Control and Prevention Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Towards the WHO goal for hepatitis elimination, understanding the prevalence and management of hepatitis B and C viruses (HBV, HCV) among drug abusers is crucial. However, in Japan, where drug abuse is less prevalent than in other countries, there is a dearth of epidemiological studies on this topic. This study aimed to fill this gap by investigating virus prevalence and the testing and treatment landscape for drug abusers in Japan. We conducted a cross-sectional sero-epidemiological study at a psychiatric hospital in Hiroshima where approaching drug abusers was feasible. Blood samples and questionnaire on HBV/HCV testing and treatment were collected from drug abusers (

Indexed as

drug abusersHBVHCVJapanmicro-eliminationsero-epidemiology

Identifiers

PMID40144738
PMCPMC11933930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.